Updated:
JSL Health Capital
JSL Health Capital invests at the intersection of healthcare and AI. They back late seed and growth-stage healthcare companies leveraging AI, data, and...
JSL Health Capital
JSL Health Capital invests at the intersection of healthcare and AI. They back late seed and growth-stage healthcare companies leveraging AI, data, and software. As former founders and operators, they act as hands-on partners helping with commercial acceleration and technology strategy and implementation.
General information
Firm type
Private Equity
Year founded
2020
Location
Region
North America
Country
United States
City
Washington
Corporate office
Washington, United States
Sector focus
Frequently asked questions
What investment stages does JSL Health Capital typically target?
JSL Health Capital focuses on expansion, late-stage, and growth equity opportunities in the healthcare sector, per the firm's official description. The firm targets companies that have already established clinical or commercial proof points and need capital to scale. This positions it after the early-stage venture window but before large-scale buyout, a segment often underserved by generalist funds.
Does JSL Health Capital invest exclusively in healthcare?
Yes. The firm's name and public positioning indicate an exclusive focus on health capital, spanning digital health, healthcare services, and enterprise software applied to the healthcare industry. There is no indication of investments outside life sciences or healthcare technology.
What is JSL Health Capital's known posture on co-investments alongside external GPs?
There is no publicly available co-investment record for JSL Health Capital at this time. Firms with a concentrated healthcare mandate and a Washington base frequently engage in co-investment alongside larger generalist firms during later-stage rounds, but no specific co-investment partners have been publicly identified for JSL Health Capital.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: